PHOENIX, June 1, 2023
/PRNewswire/ -- Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity" or
the "Company"), a leading provider of diversified financial
solutions to growth-stage companies, today announced the commitment
of $30 million in growth capital to
support Revelle's efforts in developing aesthetic solutions that
deliver meaningful results for women and reliable outcomes for
practitioners.
Revelle has gained recognition in the market with its
FDA-cleared device, Avéli, which is indicated for long-term
reduction in the appearance of cellulite as supported by clinical
data demonstrating treatment benefits through one year of
observation. This technology is well positioned to enhance the way
women address their aesthetic concerns surrounding cellulite.
Rob Lake, Senior Managing
Director, Life Sciences of Trinity, said, "We are excited to be
partnering with Revelle, an innovator in the MedTech industry.
Their disruptive approach, coupled with the support of Trinity,
will drive the development of groundbreaking technologies that
address women's aesthetic concerns in an entirely new manner."
Through this investment, Revelle aims to bolster the growth and
expansion of its operations, enabling them to further penetrate the
market. The infusion of capital will aid in driving sales and
support marketing initiatives to reach a wider customer base and
expand production capabilities.
"This partnership with Trinity marks a significant milestone in
our journey," said Caroline Van
Hove, President and CEO of Revelle Aesthetics. "Their
support and expertise will accelerate our growth trajectory,
allowing us to bring our innovative solution to a wider audience.
With this infusion of capital, we will continue pushing boundaries
and advancing our mission to empower women by providing them with
safe, effective, and long-lasting aesthetic solutions."
The market potential for women's aesthetic solutions is large
and growing. With increasing demand for effective treatments,
Revelle is strategically positioned to capture a significant share
of this market.
About Trinity Capital Inc.
Trinity Capital Inc. (Nasdaq: TRIN and TRINL), an
internally managed business development company, is a leading
provider of diversified financial solutions to growth-stage
companies with institutional equity investors. Trinity
Capital's investment objective is to generate current income
and, to a lesser extent, capital appreciation through investments,
including term loans and equipment financings and equity-related
investments. Trinity Capital believes it is one of only a
select group of specialty lenders that has the depth of knowledge,
experience and track record in lending to growth stage companies.
For more information, please visit the Company's website
at www.trinitycap.com.
Forward-Looking Statements
Statements included herein may constitute "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. Statements other than statements of historical
facts included in this press release may constitute forward-looking
statements and are not guarantees of future performance, condition
or results and involve a number of risks and uncertainties. Actual
results may differ materially from those in the forward-looking
statements as a result of a number of factors, including those
described from time to time in the Company's filings with the
Securities and Exchange Commission. Trinity undertakes no duty to
update any forward-looking statement made herein. All
forward-looking statements speak only as of the date of this press
release.
View original
content:https://www.prnewswire.com/news-releases/trinity-capital-inc-provides-30-million-growth-capital-to-revelle-aesthetics-301840653.html
SOURCE Trinity Capital Inc.